191 related articles for article (PubMed ID: 36265991)
1. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals.
Labiner AJ; Aronson A; Lucas AL
Hematol Oncol Clin North Am; 2022 Oct; 36(5):929-942. PubMed ID: 36265991
[TBL] [Abstract][Full Text] [Related]
2. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
3. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
4. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
Dudley B; Brand RE
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
7. [Pancreatic cancer-screening or surveillance?].
Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Cancer Surveillance in Carriers of a Germline
Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
[TBL] [Abstract][Full Text] [Related]
9. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
10. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
[TBL] [Abstract][Full Text] [Related]
11. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
12. Long-term yield of pancreatic cancer surveillance in high-risk individuals.
Overbeek KA; Levink IJM; Koopmann BDM; Harinck F; Konings ICAW; Ausems MGEM; Wagner A; Fockens P; van Eijck CH; Groot Koerkamp B; Busch ORC; Besselink MG; Bastiaansen BAJ; van Driel LMJW; Erler NS; Vleggaar FP; Poley JW; Cahen DL; van Hooft JE; Bruno MJ;
Gut; 2022 Jun; 71(6):1152-1160. PubMed ID: 33820756
[TBL] [Abstract][Full Text] [Related]
13. Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective.
Copur MS; Talmon GA; Wedel W; Hart JD; Merani S; Vargasi LM
Oncology (Williston Park); 2020 Jun; 34(6):196-201. PubMed ID: 32609864
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
15. Familial Pancreatic Ductal Adenocarcinoma.
Diaz KE; Lucas AL
Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
[TBL] [Abstract][Full Text] [Related]
16. Progress report: familial pancreatic cancer.
Mintziras I; Bartsch DK
Fam Cancer; 2019 Jul; 18(3):359-362. PubMed ID: 30796632
[TBL] [Abstract][Full Text] [Related]
17. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
Del Chiaro M; Zerbi A; Capurso G; Zamboni G; Maisonneuve P; Presciuttini S; Arcidiacono PG; Calculli L; Falconi M;
Dig Liver Dis; 2010 Sep; 42(9):597-605. PubMed ID: 20627831
[TBL] [Abstract][Full Text] [Related]
18. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer.
Ibrahim IS; Bonsing BA; Swijnenburg RJ; Welling L; Veenendaal RA; Wasser MN; Morreau H; Inderson A; Vasen HF
Fam Cancer; 2017 Jan; 16(1):111-115. PubMed ID: 27406244
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ultrasound-guided fine-needle aspiration for the differential diagnosis of intraductal papillary mucinous neoplasms and size stratification for surveillance.
Kadayifci A; Brugge WR
Endoscopy; 2014 Apr; 46(4):357. PubMed ID: 24671860
[No Abstract] [Full Text] [Related]
20. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
Sud A; Wham D; Catalano M; Guda NM
Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]